77 Analyzing effects of immunotherapies, such as bispecific antibodies and cellular therapy, targeting EGFR expression with a high content screening platform in patient-derived organoids

77 Analyzing effects of immunotherapies, such as bispecific antibodies and cellular therapy, targeting EGFR expression with a high content screening platform in patient-derived organoids

Bibliographic Details
Main Authors:	Gera Goverse, Sander Basten, Leo Price, Saskia de Man, Chiara Foini, Tomas Veenendaal, Sergei Chavez-Abiega, Michelle Kop, Rick Heeren, Christos Sarantaris, Daniel Okkes, Ashgard Weterings
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

eIg-based bispecific T-cell engagers targeting EGFR: Format matters
by: Lennart Kühl, et al.
Published: (2023-12-01)

A Bispecific Inhibitor of the EGFR/ADAM17 Axis Decreases Cell Proliferation and Migration of EGFR-Dependent Cancer Cells
by: Abel Soto-Gamez, et al.
Published: (2020-02-01)

Comparative Characterization of Different Molecular Formats of Bispecific Antibodies Targeting EGFR and PD-L1
by: Nishant Mohan, et al.
Published: (2022-06-01)

PTPRK, an EGFR Phosphatase, Is Decreased in CeD Biopsies and Intestinal Organoids
by: Merlin Nanayakkara, et al.
Published: (2022-12-01)

Bispecific Targeting of EGFR and Urokinase Receptor (uPAR) Using Ligand-Targeted Toxins in Solid Tumors
by: Felix Oh, et al.
Published: (2020-06-01)

Functional Domain Order of an Anti-EGFR × Anti-CD16 Bispecific Diabody Involving NK Cell Activation
by: Atsushi Kuwahara, et al.
Published: (2020-11-01)

Antitumor Activity of an Anti-EGFR/HER2 Bispecific Antibody in a Mouse Xenograft Model of Canine Osteosarcoma
by: Nami Tateyama, et al.
Published: (2022-11-01)

The mechanism of action and biodistribution of a novel EGFR/VEGF bispecific fusion protein that exhibited superior antitumor activities
by: Lan Deng, et al.
Published: (2023-06-01)

VHH-Based Bispecific Antibodies Targeting Cytokine Production
by: Maxim A. Nosenko, et al.
Published: (2017-09-01)

Targeting of colorectal cancer organoids with zoledronic acid conjugated to the anti-EGFR antibody cetuximab
by: Roberto Benelli, et al.
Published: (2022-12-01)

Engineering of a Bispecific Nanofitin with Immune Checkpoint Inhibitory Activity Conditioned by the Cross-Arm Binding to EGFR and PDL1
by: Perrine Jacquot, et al.
Published: (2023-03-01)

Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies
by: Simona Camorani, et al.
Published: (2024-03-01)

1150 DM005, an EGFR × MET bispecific antibody-drug conjugate, showed robust anti-tumor activity in PDX models
by: Jun Li, et al.
Published: (2023-11-01)

Impact of antibody architecture and paratope valency on effector functions of bispecific NKp30 x EGFR natural killer cell engagers
by: Ammelie Svea Boje, et al.
Published: (2024-12-01)

EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T cells
by: Vinicio Melo, et al.
Published: (2023-07-01)

Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR
by: Hao Zhang, et al.
Published: (2023-09-01)

Ports '77 /
Published: (1977)

FORTRAN 77 /
by: 403469 Katzan, Harry
Published: (1978)

Fortran 77 /
by: 310605 Monro, Donald Martin
Published: (1982)

AIRPORT '77 /
by: Scheff, Michael, et al.
Published: (1977)

Euromeas - 77
by: 9327 European Conference on Precise electrical measurement 1977

Fortran 77 /
by: 171669 Bezner, Hart C.
Published: (1989)

1152 DM001: A novel bispecific ADC targeting TROP2 and EGFR with potent anti-tumor efficacy in PDX models
by: Yi Yang, et al.
Published: (2023-11-01)

111In-labeled immunoconjugates (ICs) bispecific for the epidermal growth factor receptor (EGFR) and cyclin-dependent kinase inhibitor, p27Kip1.
by: Cornelissen, B, et al.
Published: (2009)

A Novel Bispecific Antibody Targeting EGFR and VEGFR2 Is Effective against Triple Negative Breast Cancer via Multiple Mechanisms of Action
by: Nishant Mohan, et al.
Published: (2021-03-01)

Fortran 77 : language and style : a structured guide to Fortran 77 /
by: 448399 Merchant, Michael J.
Published: (1981)

Bispecific antibodies for viral immunotherapy
by: Elisabeth K. Nyakatura, et al.
Published: (2017-04-01)

Introduction, issue 77
Published: (2009)

Essentials of FORTRAN 77 /
by: 372638 Shelley, John
Published: (1984)

FORTRAN 77 terstruktur /
by: 243131 Etter, Delores M.
Published: (1986)

Fortran 77 programming /
by: 460543 Brainerd, Walter S., et al.
Published: (1978)

Coastal sediments '77 /
by: American Society of Civil Engineers
Published: (1977)

Fortran 77 PDQ /
by: 189086 Boyle, Thomas A.
Published: (1989)

FORTRAN 77 for engineers /
by: 227261 Borse, G. J.
Published: (1985)

Programming with FORTRAN 77 /
by: Ashcroft, J.
Published: (1981)

FORTRAN 77 for engineers /
by: 368036 Torby, Bruce J.
Published: (1991)

Effective FORTRAN 77 /
by: 456447 Metcalf, Michael
Published: (1985)

Color 77: proceedings
by: International Color Association Congress (3rd : 1977 : New York), et al.
Published: (1978)

77 CABANG KEIMANAN /
by: Abu Al-Ma'ali Umar Abdurrahman Al-Qazwini, author 646556, et al.
Published: (2017)

A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response
by: Laura Rubio-Pérez, et al.
Published: (2023-12-01)